应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
NVOX 2倍做多NVO ETF-Defiance
盘前交易 06-18 05:45:15 EDT
13.42
-0.03
-0.22%
盘前
13.36
-0.04
-0.30%
05:42 EDT
最高
14.30
最低
13.36
成交量
55.95万
今开
14.28
昨收
13.45
日振幅
6.99%
总市值
3,943万
流通市值
3,943万
总股本
293.81万
成交额
784.48万
换手率
19.04%
流通股本
293.81万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
诺和诺德全球CEO：未来会增加在中国的BD交易，口服减重版司美将递交上市申请
澎湃新闻 · 06-17 14:22
诺和诺德全球CEO：未来会增加在中国的BD交易，口服减重版司美将递交上市申请
诺和诺德遭黑客组织窃取大量数据并勒索2500万美元
环球市场播报 · 06-17 07:59
诺和诺德遭黑客组织窃取大量数据并勒索2500万美元
上任后首次访华，诺和诺德CEO透露司美格鲁肽口服减重药即将在华递交上市申请
第一财经 · 06-16 20:30
上任后首次访华，诺和诺德CEO透露司美格鲁肽口服减重药即将在华递交上市申请
买下上海地铁站核心广告位，减重药巨头国内“混战”升级
第一财经 · 06-16 14:35
买下上海地铁站核心广告位，减重药巨头国内“混战”升级
（投资中国）诺和诺德将在天津追加投资提升产能
中国新闻网 · 06-15 21:21
（投资中国）诺和诺德将在天津追加投资提升产能
诺和诺德长效生长激素诺泽优将于今年暑期在国内全面上市
南方财经网 · 06-13
诺和诺德长效生长激素诺泽优将于今年暑期在国内全面上市
英国卫生监管机构批准诺和诺德减肥药Wegovy
老虎资讯综合 · 06-11
英国卫生监管机构批准诺和诺德减肥药Wegovy
减肥药概念股普涨 诺和诺德(NVO)涨3.14% 高盛料2030年全球减肥药市场规模将达1140亿美元
金吾财讯 · 06-10
减肥药概念股普涨 诺和诺德(NVO)涨3.14% 高盛料2030年全球减肥药市场规模将达1140亿美元
GLP-1赛道竞争加剧 辉瑞“头对头”挑战诺和诺德
新华财经 · 06-10
GLP-1赛道竞争加剧 辉瑞“头对头”挑战诺和诺德
多家药企公布“头对头”司美研究数据，诺和诺德坐不住了
澎湃新闻 · 06-09
多家药企公布“头对头”司美研究数据，诺和诺德坐不住了
比司美格鲁肽多减35%体重！辉瑞减肥药能否突破GLP-1药物疗效瓶颈
第一财经 · 06-08
比司美格鲁肽多减35%体重！辉瑞减肥药能否突破GLP-1药物疗效瓶颈
诺和诺德减肥口服药上市以来处方量已达300万份
环球市场播报 · 06-08
诺和诺德减肥口服药上市以来处方量已达300万份
诺和诺德、联合健康盘前跌超1%
每日经济新闻 · 06-08
诺和诺德、联合健康盘前跌超1%
诺和诺德：司美格鲁肽2毫克在一年期试验中，糖化血红蛋白达标率与替尔泊肽相当，减重达标率更优
美股速递 · 06-06
诺和诺德：司美格鲁肽2毫克在一年期试验中，糖化血红蛋白达标率与替尔泊肽相当，减重达标率更优
需求扩容抵消降价压力 GLP-1赛道远期市场空间再度上调
金吾财讯 · 06-05
需求扩容抵消降价压力 GLP-1赛道远期市场空间再度上调
礼来、诺和诺德涨超5%，多项并购、研发进展及产能优化利好共振
异动解读 · 06-04
礼来、诺和诺德涨超5%，多项并购、研发进展及产能优化利好共振
诺和诺德在阿联酋上市维格维口服减肥药，系美国以外首个落地市场
环球市场播报 · 06-03
诺和诺德在阿联酋上市维格维口服减肥药，系美国以外首个落地市场
Gate 股票衍生品专区将首发上线 NVO（诺和诺德）、NOK（诺基亚）等 6 个永续合约交易
链捕手 · 06-01
Gate 股票衍生品专区将首发上线 NVO（诺和诺德）、NOK（诺基亚）等 6 个永续合约交易
诺和诺德：印度批准维格维用于青少年群体
环球市场播报 · 05-29
诺和诺德：印度批准维格维用于青少年群体
诺和诺德高剂量Wegovy单剂量注射笔获欧盟CHMP积极意见
环球市场播报 · 05-23
诺和诺德高剂量Wegovy单剂量注射笔获欧盟CHMP积极意见
暂无数据
公司概况
公司名称：
2倍做多NVO ETF-Defiance
所属市场：
ARCA
上市日期：
--
主营业务：
发行价格：
--
{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":13.42,"timestamp":1781726400000,"preClose":13.45,"halted":0,"volume":559544,"hourTrading":{"tag":"盘前","latestPrice":13.36,"preClose":13.4001,"latestTime":"05:42 EDT","volume":2147,"amount":29060.190338,"timestamp":1781775774194,"change":-0.0401,"changeRate":-0.002993,"amplitude":0.019403},"delay":0,"changeRate":-0.002230483271375417,"floatShares":2938101,"shares":2938101,"eps":0,"marketStatus":"盘前交易","change":-0.03,"latestTime":"06-18 05:45:15 EDT","open":14.28,"high":14.3,"low":13.36,"amount":7844762.11648,"amplitude":0.069888,"askPrice":13.37,"askSize":1750,"bidPrice":13.35,"bidSize":50,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781789400000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":13.4001,"sharesOutstanding":4128101,"nav":13.42,"aum":39429315.42,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":13.36,"preClose":13.4001,"latestTime":"05:42 EDT","volume":2147,"amount":29060.190338,"timestamp":1781775774194,"change":-0.0401,"changeRate":-0.002993,"amplitude":0.019403},"postHourTrading":{"tag":"盘后","latestPrice":13.47,"preClose":13.42,"latestTime":"19:37 EDT","volume":14768,"amount":198468.8742,"timestamp":1781739452907,"change":0.05,"changeRate":0.003726,"amplitude":0.007221},"volumeRatio":0.986807970540482,"impliedVol":0.6479,"impliedVolPercentile":0.1406},"requestUrl":"/m/hq/s/NVOX/tweets","defaultTab":"tweets","newsList":[{"id":"2644715895","title":"诺和诺德全球CEO：未来会增加在中国的BD交易，口服减重版司美将递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715895","media":"澎湃新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644715895?lang=zh_cn&edition=full","pubTime":"2026-06-17 14:22","pubTimestamp":1781677320,"startTime":"0","endTime":"0","summary":"“我们一直与许多中国公司对话，并将继续下去。当我们找到合适的公司或分子，能补充我们感兴趣的领域时，我们不会犹豫提出报价。”6月16日，诺和诺德公司全球总裁兼首席执行官杜麦克（MaziarMikeDoustdar）在接受澎湃新闻记者采访时表示，未来诺和诺德在中国的BD交易会增加，这是肯定的。近几年，BD（业务拓展）已成为中国创新药出海的重要路径。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606173774451184.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606173774451184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756325.SGD","BK4532","BK4588","LU1093756168.USD","NVOX","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4599","BK4007","LU0154236417.USD","BK4585","NVO","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644796603","title":"诺和诺德遭黑客组织窃取大量数据并勒索2500万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644796603","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644796603?lang=zh_cn&edition=full","pubTime":"2026-06-17 07:59","pubTimestamp":1781654340,"startTime":"0","endTime":"0","summary":"一个网络勒索组织周二声称，他们从制药巨头诺和诺德公司窃取了超过 1TB 的数据，在向该公司索要2500万美元赎金未果后，正在考虑出售部分数据。 这个名为FulcrumSec的网络勒索组织于2025年10月成立。该组织在其网站上发布长文称，他们潜入诺和诺德的网络长达两个多月，窃取了相关数据。 FulcrumSec在一封电子邮件中表示，诺和诺德公司的代表于6月3日联系了该组织，大约在FulcrumSec首次联系该公司未具名高管48小时后。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-17/doc-inicsmhz3885133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVOX","BK4007","IE00BZ1G4Q59.USD","BK4532","BK4588","NVO","IE00BKVL7J92.USD","LU1093756168.USD","LU0154236417.USD","NVOH","LU1093756325.SGD","BK4585","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643757340","title":"上任后首次访华，诺和诺德CEO透露司美格鲁肽口服减重药即将在华递交上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2643757340","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643757340?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:30","pubTimestamp":1781613031,"startTime":"0","endTime":"0","summary":"6月16日，诺和诺德全球CEO杜麦克（MaziarMikeDoustdar）在北京接受专访时向第一财经记者透露，诺和诺德最快有望于未来数周内递交司美格鲁肽口服减重片剂在华上市申请。杜麦克此次访华是他自去年8月担任公司CEO以来的首次访华，同行的还有公司全球高管及董事会成员。他在采访中向第一财经记者强调，中国是诺和诺德重要的战略性市场，也是仅次于美国的全球第二大市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606163773314572.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163773314572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756325.SGD","NVOH","LU1093756168.USD","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD","BK4588","BK4585","LU0154236417.USD","BK4532","BK4007","BK4599","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643273193","title":"买下上海地铁站核心广告位，减重药巨头国内“混战”升级","url":"https://stock-news.laohu8.com/highlight/detail?id=2643273193","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643273193?lang=zh_cn&edition=full","pubTime":"2026-06-16 14:35","pubTimestamp":1781591705,"startTime":"0","endTime":"0","summary":"最近，在上海核心区域乘坐地铁时，很多人会发现减重药广告开始打进人流密集的地铁站。在2号线等多条地铁线交汇的南京西路站，美团买药联手信达生物以“科学体重管理，让脂肪肝逆转”为名，打出整条长廊的巨幅广告；在仅一站之隔的静安寺地铁站，礼来也挂出“阻塞性睡眠呼吸暂停”（OSA）的科普宣传海报。“减重药广告已经无处不在，想不看见都不行。”有网友感叹道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606163772949792.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606163772949792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0154236417.USD","LU2242644610.SGD","LU1983299246.USD","LU0321505868.SGD","LU1988902786.USD","LU2756315664.SGD","LU0823434583.USD","IE00BKDWB100.SGD","BK4599","ELIS","IE0004445239.USD","LU2106854487.HKD","LU1232071149.USD","BK4568","LU1629891620.HKD","LU2357305700.SGD","NVO","LU0353189680.USD","LU0786609619.USD","IE00B2B36J28.USD","LU1366192091.USD","LU2491050154.USD","IE00BBT3K403.USD","HK0000165453.HKD","NVOX","SGXZ99366536.SGD","LU2237443622.USD","LU0823434740.USD","LU2089984988.USD","LU2211815571.USD","SGXZ57979304.SGD","SG9999015978.USD","LU0203201768.USD","BK1583","LU0210536198.USD","LU1917777945.USD","LLYX","LU2328871848.SGD","LU1720051108.HKD","LU2089284900.SGD","SG9999018865.SGD","IE00BJJMRY28.SGD","LU0122379950.USD","LU0234572021.USD","LU0471298694.HKD","LU0820561818.USD","SG9999002232.USD","LU0943347566.SGD","BK4533","LU2746668974.SGD","LU0820561909.HKD","IE00BJT1NW94.SGD","LU0256863811.USD","LU2602419157.SGD","SG9999015945.SGD","LU0097036916.USD","LU0320765059.SGD","LU1868836591.USD","LU2028103732.USD","BK4581","LU1061106388.HKD","SG9999015952.SGD","LU2097828631.EUR","IE00BK4W5L77.USD","SG9999018857.SGD","BK4534","LU1868836914.USD","IE0004445015.USD","IE00BJJMRZ35.SGD","LU2471134796.USD","SG9999013999.USD","SG9999014906.USD","LU0882574055.USD","LU1974910355.USD","LU1066053197.SGD","LU2361044865.SGD","ELIL","LU0640476718.USD","LU1023059063.AUD","LU1548497426.USD","IE00BFTCPJ56.SGD","LU2552382058.USD","LU0456855351.SGD","LU0868494617.USD","LU2063271972.USD","LU0058720904.USD","LU2361044949.HKD","PFE","LU0417517546.SGD","LU0225771236.USD","LU0170899867.USD","IE00BK4W5M84.HKD","LU1551013342.USD","LU1868836757.USD","LU2089283258.USD","LU2746668461.USD","LU2488822045.USD","IE00B3T34201.USD","LU0266013472.USD","IE00BFSS8Q28.SGD","LU1712237335.SGD","IE00B775H168.HKD","IE0002270589.USD","LU0889565916.HKD","LU0106261372.USD","LU0964807845.USD","LU0354030511.USD","BK4007","IE00BZ1G4Q59.USD","LU0158827948.USD","LU0985481810.HKD","LU0683600562.USD","LU2237443465.HKD","LU2237443895.HKD","BK1161","LU1883839398.USD","LU0158827781.USD","LU1868837300.USD","LLY","LU2468319806.SGD","SG9999015986.USD","LU2237443549.SGD","SG9999003800.SGD","LU1069344957.HKD","LU0133085943.USD","LLII","IE00BN29S564.USD","LU2417539215.USD","BK4592","LU2360106947.USD","IE00BKPKM429.USD","SG9999014880.SGD","BK4550","LU0466842654.USD","LU2097828714.EUR","LU0096364046.USD","IE00B19Z3581.USD","IE00BWXC8680.SGD","LU0225284248.USD","LU0882574139.USD","LU2265009873.SGD","01801","LU2111349929.HKD","LU0203202063.USD","IE00B1XK9C88.USD","LU1894683264.USD","LU2361045086.USD","LU0385154629.USD","LU2087625088.SGD","IE00BKVL7J92.USD","LU2168564495.EUR","LU1969619763.USD","LU0306806265.USD","LU1035775433.USD","LU1804176565.USD","LU2023251221.USD","LU2461242641.AUD","LU2491049909.HKD","SG9999002224.SGD","LU2471134879.HKD","SG9999014898.SGD","SG9999017495.SGD","LU0289739699.SGD","LU1145028129.USD","LU2491050071.SGD","LU0432979614.USD","LU0353189763.USD","LU1066051498.USD","LU0225283273.USD","LU1093756325.SGD","LU0471298777.SGD","IE00BJLML261.HKD","LU2237438978.USD","LU0316494557.USD","LU1989771016.USD","LU2168563687.JPY","IE00B19Z3B42.SGD","LU0114720955.EUR","LU2456880835.USD","LU0320765992.SGD","IE00BLSP4239.USD","NVOH","LU2097828474.EUR","LU2237443382.USD","LU0198837287.USD","LU2264538146.SGD","LU0109394709.USD","LU2108987350.USD","LU2552382132.HKD","IE00BLSP4452.SGD","LU2097828805.USD","LU0672654240.SGD","LU1093756168.USD","LU1623119135.USD","IE00B7KXQ091.USD","BK4585","LU1894683348.USD","LU2462157665.USD","LU2023250330.USD","LU2271345857.HKD","LU2213496289.HKD","LU1323610961.USD","LU2097828557.USD","GB00BDT5M118.USD","LU1057294990.SGD","LU1720051017.SGD","LU0354030438.USD","LU2750360997.AUD","SG9999011175.SGD","LU1291159041.SGD","LU0306807586.USD","SGXZ31699556.SGD","LU2023250504.SGD","LU0109391861.USD","IE00BFSS7M15.SGD","LU2471134523.USD","LU0823416689.USD","LU1267930730.SGD","BK4516","LU1814569148.SGD","LU2750360641.GBP","SG9999001176.SGD","IE0002141913.USD","SG9999014914.USD","LU2896262040.SGD","SGXZ51526630.SGD","LU0256863902.USD","BK1589","LU0323591593.USD","LU1551013425.SGD","LU2552382215.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","SGXZ81514606.USD","IE0001KFT4U8.USD","LU0094547139.USD","LU0006306889.USD","LU2112291526.USD","LU1868837136.USD","LU0238689110.USD","LU2596442595.SGD","LU2237443978.SGD","LU2324357040.USD","LU0079474960.USD","LU1127390331.HKD","LU0455707207.USD","LU2168564065.EUR","LU2168564222.USD","IE000M9KFDE8.USD","LU0321505439.SGD","LU2471134952.CNY","LU0061475181.USD","LU1280957306.USD","IE0005OL40V9.USD","LU2236285917.USD","LU2756315318.SGD","LU0502904849.HKD","IE00B4JS1V06.HKD","BK4532","IE00B1BXHZ80.USD","LU1064131342.USD","LLYZ","LU0708995401.HKD","LU0820562030.AUD","LU0689472784.USD","LU0787776722.HKD","SG9999001176.USD","IE00BJJMRX11.SGD","LU2168564149.EUR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206006","title":"（投资中国）诺和诺德将在天津追加投资提升产能","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206006","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643206006?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:21","pubTimestamp":1781529669,"startTime":"0","endTime":"0","summary":"中新社天津6月15日电全球知名的丹麦生物制药企业诺和诺德15日宣布，将向位于天津的战略生产基地追加投资2亿元(人民币，下同)，用于提升1.5毫升畅充注射笔组装产能。此次追加投资系诺和诺德全球高管团队访华期间公布。项目建成后，将显著提高相关产品的产能与供应效率，以满足中国患者日益多元化的用药需求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606153771817294.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606153771817294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1093756168.USD","BK4585","LU0154236417.USD","NVOH","BK4007","NVOX","IE00BKVL7J92.USD","BK4588","NVO","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4532","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643321101","title":"诺和诺德长效生长激素诺泽优将于今年暑期在国内全面上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2643321101","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643321101?lang=zh_cn&edition=full","pubTime":"2026-06-13 17:23","pubTimestamp":1781342580,"startTime":"0","endTime":"0","summary":"南方财经6月13日电，诺和诺德今日宣布，其长效生长激素注射液诺泽优?（帕西生长激素）将于今年暑期在中国全面上市，为因内源性生长激素分泌不足所致生长迟缓的2.5岁及以上的中国儿童患者带来每周一次的治疗新选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606133770590837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4007","IE00BKVL7J92.USD","LU1093756168.USD","LU1093756325.SGD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","BK4599","NVO","NVOX","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182087964","title":"英国卫生监管机构批准诺和诺德减肥药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1182087964","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182087964?lang=zh_cn&edition=full","pubTime":"2026-06-11 23:19","pubTimestamp":1781191158,"startTime":"0","endTime":"0","summary":"英国药品监管机构周四批准了诺和诺德的减肥药片，为患者提供了一种无需注射的肥胖治疗新选择，同时也巩固了这家丹麦药企相对于美国竞争对手礼来的先发优势。诺和诺德预计，该药将在数周内通过私立处方上市。根据英国国家医疗服务体系的最新估算，英格兰约有30%的成年人受肥胖影响，相当于约1300万至1400万人。诺和诺德这款药片含有司美格鲁肽，与其旗下用于减肥的注射型重磅药物Wegovy及用于糖尿病的Ozempic具有相同的活性成分。","market":"us","thumbnail":"https://community-static.tradeup.com/news/4812f8e146094a91d24ad513651fcb26","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4812f8e146094a91d24ad513651fcb26"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a4d9db3d57fa8633379c890f70b5f1d9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","NVO","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642424467","title":"减肥药概念股普涨 诺和诺德(NVO)涨3.14% 高盛料2030年全球减肥药市场规模将达1140亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642424467","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642424467?lang=zh_cn&edition=full","pubTime":"2026-06-10 22:17","pubTimestamp":1781101035,"startTime":"0","endTime":"0","summary":"高盛新近研究指，预计到2030年，全球减肥药市场规模将达到1140亿美元，较去年12月作出的1010亿美元预测进一步上调约13%，因一系列利好因素正在推动这一赛道从“小众高价市场”向“大众消费级市场”转变。基于这一趋势，高盛预计，到2030年口服减肥药将贡献约460亿美元收入，占全球肥胖症药物市场规模的40%，高于此前预计的350亿美元和35%的市场占比。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301402","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKVL7J92.USD","LU1093756168.USD","BK4532","LU1093756325.SGD","BK4007","LU0154236417.USD","NVOH","BK4599","NVO","NVOX","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642419178","title":"GLP-1赛道竞争加剧 辉瑞“头对头”挑战诺和诺德","url":"https://stock-news.laohu8.com/highlight/detail?id=2642419178","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642419178?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:35","pubTimestamp":1781055326,"startTime":"0","endTime":"0","summary":"新华财经北京6月10日电近日，辉瑞公布其GLP-1受体激动剂埃诺格鲁肽（先维盈?）与诺和诺德司美格鲁肽（诺和盈?）的头对头研究——SLIMMER-UP-SWITCH的20周中期分析结果，显示埃诺格鲁肽在减重数值上略优于司美格鲁肽。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606103766030185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IE00BKVL7J92.USD","BK4532","LU0170899867.USD","LU1057294990.SGD","IE000M9KFDE8.USD","SG9999002232.USD","LU0321505868.SGD","SG9999011175.SGD","IE00BBT3K403.USD","SG9999001176.SGD","SG9999003800.SGD","BK4588","BK4592","IE00B19Z3B42.SGD","LU1093756168.USD","LU1066051498.USD","BK4568","BK4599","LU1894683264.USD","SG9999013999.USD","BK4534","NVOX","LU0058720904.USD","LU2596442595.SGD","LU0306807586.USD","LU0154236417.USD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU0321505439.SGD","NVO","SGXZ57979304.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","LU0868494617.USD","LU0225284248.USD","IE00B19Z3581.USD","LU0122379950.USD","PFE","BK4581","LU0985481810.HKD","IE00BLSP4239.USD","LU1883839398.USD","LU1093756325.SGD","NVOH","SG9999002224.SGD","BK4533","LU1023059063.AUD","SG9999001176.USD","IE00B3T34201.USD","BK4585","BK4550","LU0306806265.USD","LU0225771236.USD","BK4007","LU1066053197.SGD","LU0456855351.SGD","LU1894683348.USD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642137467","title":"多家药企公布“头对头”司美研究数据，诺和诺德坐不住了","url":"https://stock-news.laohu8.com/highlight/detail?id=2642137467","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642137467?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:44","pubTimestamp":1781005440,"startTime":"0","endTime":"0","summary":"减肥药赛道再起波澜！因为一项减肥药的头对头研究数据，诺和诺德向辉瑞“开怼”。6月9日，减肥药巨头诺和诺德中国针对近期在2026年美国糖尿病协会（ADA）科学年会上公布的SLIMMER-UP-SWITCH研究的20周中期分析数据发布了一份说明称：“对于任何单一研究，均需在更完整的数据披露和多维度证据支持下进行综合、科学评估，避免片面解读带来的潜在误导。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606093765289066.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606093765289066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0058720904.USD","LU0234572021.USD","BK4534","LU1066053197.SGD","BK4533","NVOX","SG9999013999.USD","LU0225284248.USD","LU0306807586.USD","IE00BZ1G4Q59.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","SG9999011175.SGD","BK4568","BK4532","LU0868494617.USD","SG9999003800.SGD","LU1883839398.USD","LU1093756168.USD","SG9999001176.SGD","SG9999002232.USD","IE000M9KFDE8.USD","LU0985481810.HKD","LU1066051498.USD","NVOH","LU1023059063.AUD","LU0321505439.SGD","BK4585","BK4007","LU0154236417.USD","LU0456855351.SGD","IE00BKVL7J92.USD","LU1894683348.USD","LU0122379950.USD","PFE","IE00B3T34201.USD","SG9999001176.USD","BK4550","IE00B19Z3581.USD","LU1093756325.SGD","LU0321505868.SGD","LU2596442595.SGD","BK4588","IE00BLSP4452.SGD","LU0289739699.SGD","LU0225771236.USD","SG9999002224.SGD","IE0002270589.USD","LU0170899867.USD","BK4599","BK4592","IE00BBT3K403.USD","BK4581","LU0306806265.USD","SGXZ57979304.SGD","LU1894683264.USD","NVO","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100049","title":"比司美格鲁肽多减35%体重！辉瑞减肥药能否突破GLP-1药物疗效瓶颈","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100049","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100049?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:17","pubTimestamp":1780910222,"startTime":"0","endTime":"0","summary":"国内GLP-1减肥药市场的竞争，已从“有无”之争进入到拼疗效阶段。6月8日，辉瑞宣布其GLP-1受体激动剂埃诺格鲁肽与司美格鲁肽的头对头研究（SLIMMER-UP-SWITCH）关键数据，在2026年美国糖尿病协会（ADA）科学年会上作为“最新突破（LateBreaking）”正式公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763671017.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763671017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4599","NVOH","SG9999013999.USD","NVO","IE00BLSP4239.USD","LU1093756168.USD","IE00BLSP4452.SGD","LU0122379950.USD","LU0321505439.SGD","LU0306806265.USD","LU1894683264.USD","IE00B19Z3B42.SGD","PFE","IE00BZ1G4Q59.USD","SG9999001176.USD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999011175.SGD","SG9999003800.SGD","LU0225771236.USD","LU0058720904.USD","LU1093756325.SGD","LU0170899867.USD","LU1023059063.AUD","LU0868494617.USD","LU0456855351.SGD","LU1066053197.SGD","LU1883839398.USD","BK4581","LU0225284248.USD","NVOX","BK4532","SG9999001176.SGD","SG9999002232.USD","LU0234572021.USD","BK4568","IE00B3T34201.USD","BK4592","IE000M9KFDE8.USD","LU0321505868.SGD","LU0985481810.HKD","BK4585","IE00BKVL7J92.USD","BK4588","IE0002270589.USD","LU0154236417.USD","BK4534","LU1057294990.SGD","LU0306807586.USD","BK4533","SGXZ57979304.SGD","BK4550","LU1894683348.USD","IE00B19Z3581.USD","LU1066051498.USD","LU2596442595.SGD","BK4007","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100657","title":"诺和诺德减肥口服药上市以来处方量已达300万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100657","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100657?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:07","pubTimestamp":1780909620,"startTime":"0","endTime":"0","summary":"诺和诺德表示，其减肥口服药维秀美自1月初上市以来，处方量已超过300万份。 这家丹麦制药商周日晚间表示，该口服药在美国药店和在线供应商上架12周后，处方量达到100万份，并在随后的10周内又开出了200万份处方。 维秀美口服药超过80%的新处方是开给首次使用GLP-1类药物的患者。 在最初于美国推出维秀美口服药后，诺和诺德上周宣布该药物在阿联酋上市，并表示正准备在今年下半年进行更多地区的上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-08/doc-iniaswmn5428087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","NVOX","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVO","BK4532","NVOH","BK4599","BK4585","LU0154236417.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641110756","title":"诺和诺德、联合健康盘前跌超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641110756","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641110756?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:25","pubTimestamp":1780907108,"startTime":"0","endTime":"0","summary":"诺和诺德、联合健康盘前跌超1%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763608225.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763608225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0861579265.USD","IE0001KFT4U8.USD","LU1718418525.SGD","LU2133065610.SGD","LU2108987350.USD","LU1791710400.SGD","LU0149725797.USD","LU1366192091.USD","LU1232071149.USD","LU2168564065.EUR","LU2347655156.SGD","LU0965509010.AUD","LU0266013472.USD","LU2237438978.USD","LU0061475181.USD","LU2087625088.SGD","LU2361045086.USD","LU1720051108.HKD","LU1623119135.USD","IE00BZ9MQY76.HKD","BK4534","BK4154","LU1854103824.USD","SG9999014880.SGD","LU0417517546.SGD","IE00BJLML261.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2237443622.USD","IE00BKVL7J92.USD","LU1066053197.SGD","LU2237443978.SGD","LU2552382215.SGD","LU0528227936.USD","LU0949170772.SGD","SG9999018865.SGD","LU0158827781.USD","LU2106854487.HKD","LU1261432733.SGD","SG9999015986.USD","BK4533","LU1127390331.HKD","LU2746668974.SGD","LU0158827948.USD","LU1267930490.SGD","LU2063271972.USD","LU1674673428.USD","IE00BWXC8680.SGD","LU2468319806.SGD","NVOH","LU0545039389.USD","SG9999017495.SGD","IE00BZ1G4Q59.USD","LU1670627923.USD","LU0053666078.USD","LU2357305700.SGD","LU2361044949.HKD","SGXZ31699556.SGD","LU0345770308.USD","LU1069344957.HKD","LU2089984988.USD","LU0077335932.USD","SGXZ99366536.SGD","IE0004445015.USD","LU0965509283.SGD","LU2211815571.USD","LLYZ","LLII","LU1064131342.USD","LU1548497426.USD","LU2023250330.USD","LU0234572021.USD","BK4599","LU0320765059.SGD","LU0079474960.USD","LU1551013425.SGD","LU0203201768.USD","LU2168564495.EUR","LU1917777945.USD","LU1868836757.USD","IE00BKDWB100.SGD","LU0553294199.USD","LU2111349929.HKD","SG9999014906.USD","LU1506573853.SGD","LU1551013342.USD","LU0353189763.USD","IE00BJT1NW94.SGD","LU1280957306.USD","LU0661504455.SGD","SG9999001176.USD","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1057294990.SGD","LU2471134879.HKD","LU1291159041.SGD","LU0289739699.SGD","LU0456855351.SGD","LU0198837287.USD","LU2265009873.SGD","LU1061106388.HKD","LU2471134523.USD","IE0009355771.USD","LU2125154935.USD","LU0738911758.USD","LU0708994859.HKD","LU0943347566.SGD","LU2896262040.SGD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","BK4566","LU0109394709.USD","LU0225283273.USD","LU0342679015.USD","LU1496350502.SGD","UNHW","LU1267930730.SGD","LU1670628061.USD","LU1153585028.USD","LU0557290698.USD","LU0823434583.USD","LU0689472784.USD","LU0210536198.USD","LU2089283258.USD","LU0820561909.HKD","IE00BK4W5L77.USD","LU2491050154.USD","LU0795875086.SGD","LU0823416689.USD","IE00BKPKM429.USD","LU2237443549.SGD","LU0496365809.HKD","LU0976567544.SGD","IE0004445239.USD","LU0211326755.USD","LU0058720904.USD","LU0965509101.SGD","NVO","LU1988902786.USD","LU1323610961.USD","LU1989771016.USD","LU2237443382.USD","IE00B4R5TH58.HKD","LU0466842654.USD","LU0203347892.USD","LU2362540622.SGD","LU1804176565.USD","LU2242649171.HKD","LU0052756011.USD","SG9999014914.USD","GB00BDT5M118.USD","LU0187121727.USD","LLY","IE00BFSS7M15.SGD","LU0432979614.USD","IE00B775H168.HKD","LU2112291526.USD","LU2360032135.SGD","IE00B4JS1V06.HKD","SG9999015952.SGD","IE0005OL40V9.USD","LU0211328371.USD","LU2552382132.HKD","LU0471298777.SGD","LU0385154629.USD","SG9999015978.USD","LU0316494557.USD","IE00B19Z8X17.USD","ELIS","LU1868836591.USD","LU2244417387.USD","LU0820562030.AUD","NVOX","LU1093756325.SGD","LU0097036916.USD","LU2552382058.USD","SGXZ51526630.SGD","LU0096364046.USD","IE00BJJMRY28.SGD","LU1629891620.HKD","LU0708995401.HKD","LU0882574139.USD","SG9999015945.SGD","LU2023251221.USD","SG9999002224.SGD","LU1093756168.USD","LU0683600562.USD","LU0094547139.USD","LU0133085943.USD","LU2023250504.SGD","LU2756315664.SGD","LU2125154778.USD","LLYX","LU2213496289.HKD","LU0965508806.USD","LU1974910355.USD","LU1914381329.SGD","LU0011850046.USD","LU1934455863.HKD","ELIL","LU1035773651.USD","LU2746668461.USD","LU0203345920.USD","LU2279689827.SGD","LU2461242641.AUD","LU0672654240.SGD","UNHG","LU1069347547.HKD","IE00B19Z9P08.USD","LU0203202063.USD","LU0029864427.USD","LU2456880835.USD","BK4581","LU0640476718.USD","LU1267930227.SGD","LU1854104046.USD","LU2264538146.SGD","LU0964807845.USD","LU1066051225.USD","LU1868837136.USD","LU0256863811.USD","BK4588","IE00B19Z9Z06.USD","BK4516","LU1074936037.SGD","LU1267930573.SGD","LU0114720955.EUR","LU1674673691.USD","SG9999018857.SGD","LU0310799852.SGD","LU0354030438.USD","LU2462157665.USD","LU0310800379.SGD","LU2602419157.SGD","LU1066051811.HKD","LU1934455277.USD","LU1983299246.USD","LU0823434740.USD","LU1037948541.HKD","LU2271345857.HKD","LU2236285917.USD","IE00B19Z9505.USD","LU1791710582.SGD","SG9999013999.USD","LU2471134952.CNY","IE00B19Z8W00.USD","IE00BN29S564.USD","LU2324357040.USD","IE00B3T34201.USD","LU1035775433.USD","LU2237443465.HKD","LU2491050071.SGD","LU1868836914.USD","LU1084165304.USD","BK4585","IE00B1BXHZ80.USD","LU1712237335.SGD","LU2756315318.SGD","LU2360106947.USD","LU0256863902.USD","IE00B2B36J28.USD","LU0353189680.USD","IE00BJJMRX11.SGD","LU0323591593.USD","LU1023059063.AUD","LU0889565916.HKD","LU1720051017.SGD","LU0109391861.USD","IE0002141913.USD","LU2750360997.AUD","LU0107464264.USD","LU1778281490.HKD","LU2168563687.JPY","IE00B1XK9C88.USD","LU0912757837.SGD","LU2750360641.GBP","LU1119994496.HKD","LU0310800965.SGD","LU0251132253.USD","LU0786609619.USD","LU1145028129.USD","LU0787776722.HKD","LU0238689110.USD","LU2089284900.SGD","LU0106261372.USD","LU2362541513.USD","LU1732799900.SGD","LU0354030511.USD","LU0471298694.HKD","LU1037948897.HKD","LU0006306889.USD","LU2237443895.HKD","LU0128525929.USD","LU2361044865.SGD","LU2168564222.USD","SG9999014898.SGD","SG9999002232.USD","LU1814569148.SGD","IE00BFXG1179.USD","LU2491049909.HKD","BK4532","IE00BJJMRZ35.SGD","LU0211326839.USD","LU0128525689.USD","LU2168564149.EUR","LU2417539215.USD","IE00BFSS8Q28.SGD","LU2471134796.USD","LU1868837300.USD","IE00B19Z3581.USD","LU2362541273.HKD","UNH","LU1003077747.HKD","IE00B7KXQ091.USD","LU0345770993.USD","LU0882574055.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU1934455194.USD","LU2028103732.USD","LU0154236417.USD","IE00BSNM7G36.USD","LU1732800096.USD","IE0002270589.USD","LU0048584097.USD","IE00B894F039.SGD","LU0122379950.USD","LU0795875169.SGD","BK4007","SG9999001176.SGD","IE00BK4W5M84.HKD","LU0820561818.USD","LU0211327993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180373682","title":"诺和诺德：司美格鲁肽2毫克在一年期试验中，糖化血红蛋白达标率与替尔泊肽相当，减重达标率更优","url":"https://stock-news.laohu8.com/highlight/detail?id=1180373682","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180373682?lang=zh_cn&edition=full","pubTime":"2026-06-06 21:04","pubTimestamp":1780751047,"startTime":"0","endTime":"0","summary":"诺和诺德公司研发的司美格鲁肽2毫克剂量，在一项为期一年的临床试验数据中，展现出与礼来公司替尔泊肽在关键血糖控制指标上的同等效力，并在减重效果上实现了超越。\n具体数据显示，接受司美格鲁肽2毫克治疗的患者，其糖化血红蛋白水平成功降至7%以下的比例，与使用替尔泊肽的患者群体相当。然而，在衡量减重效果的另一个关键终点上，司美格鲁肽表现更为突出：治疗一年后，实现体重减轻至少5%的患者比例显著高于替尔泊肽组。\n这一对比结果，为评估这两款在糖尿病与肥胖症治疗领域占据重要地位的药物提供了新的临床依据，凸显了司美格鲁肽在促进显著减重方面的潜在优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU0417517546.SGD","LU1061106388.HKD","LU2756315664.SGD","IE00B2B36J28.USD","SG9999015986.USD","SG9999001176.USD","LU2491050154.USD","LU2602419157.SGD","LU0353189680.USD","IE00B7KXQ091.USD","LU1267930730.SGD","LU1868836914.USD","LU2023250504.SGD","LU0882574055.USD","LU1712237335.SGD","LU0640476718.USD","LU0316494557.USD","LU2491050071.SGD","IE00BJJMRX11.SGD","LU0158827948.USD","LU0154236417.USD","LU2471134879.HKD","IE00BN29S564.USD","SG9999014898.SGD","LLY","LU2089284900.SGD","NVOX","LU2028103732.USD","LU2023250330.USD","LU2417539215.USD","BK4588","LU2168564222.USD","LU0820561818.USD","SGXZ99366536.SGD","SG9999015978.USD","LU0354030438.USD","BK4007","SG9999018857.SGD","LU2112291526.USD","IE00BKVL7J92.USD","LU2750360997.AUD","IE00BJLML261.HKD","IE00BFSS7M15.SGD","IE0004445239.USD","LU2896262040.SGD","LU2750360641.GBP","LU2265009873.SGD","LU0787776722.HKD","LU0820562030.AUD","LU0820561909.HKD","LU1280957306.USD","BK4599","LU2106854487.HKD","LU1232071149.USD","LU2168563687.JPY","LU0683600562.USD","IE00BZ1G4Q59.USD","LU2361044949.HKD","IE0004445015.USD","SG9999013999.USD","LU1551013342.USD","SG9999014914.USD","LU0432979614.USD","NVO","LU0823416689.USD","LU1868837136.USD","LU2756315318.SGD","LU2491049909.HKD","SGXZ57979304.SGD","LU0133085943.USD","LU1814569148.SGD","IE00B1XK9C88.USD","LU2552382132.HKD","LU2746668461.USD","LU1974910355.USD","NVOH","SG9999017495.SGD","SGXZ51526630.SGD","LU2237443978.SGD","LU0094547139.USD","LU1989771016.USD","LU0456855351.SGD","LU2552382215.SGD","LU0097036916.USD","LU1035775433.USD","LU0079474960.USD","LU2471134952.CNY","LU0061475181.USD","LU0122379950.USD","LU2168564065.EUR","LU2324357040.USD","LU2360106947.USD","IE00BWXC8680.SGD","LU1366192091.USD","IE00BK4W5L77.USD","LU0225283273.USD","LU1093756168.USD","IE00B4JS1V06.HKD","LU0353189763.USD","BK4534","BK4585","LU0210536198.USD","LU0320765992.SGD","LU2089984988.USD","LU0471298777.SGD","LU0238689110.USD","LU0466842654.USD","LU2357305700.SGD","LU2361044865.SGD","BK4533","IE00BFSS8Q28.SGD","SGXZ81514606.USD","LU0289739699.SGD","LLYX","LU2168564495.EUR","LU1057294990.SGD","LU1127390331.HKD","IE00B1BXHZ80.USD","LU2361045086.USD","LU2111349929.HKD","BK4532","LU0672654240.SGD","LU1983299246.USD","LU2108987350.USD","LU2089283258.USD","LU0471298694.HKD","ELIS","SG9999018865.SGD","LU0823434583.USD","IE00BJJMRZ35.SGD","LLII","IE0002141913.USD","LU2552382058.USD","LU0823434740.USD","LU1917777945.USD","LU2264538146.SGD","LU1323610961.USD","LU0109391861.USD","LU2211815571.USD","LU2213496289.HKD","IE0005OL40V9.USD","LU2063271972.USD","LU2471134796.USD","SG9999001176.SGD","LU2237443622.USD","LU0320765059.SGD","LU1988902786.USD","IE00BKPKM429.USD","LU2237443465.HKD","SG9999014906.USD","LU0689472784.USD","LU0889565916.HKD","LU1023059063.AUD","LU1804176565.USD","LU2168564149.EUR","LU2746668974.SGD","LU0158827781.USD","LU1868836757.USD","LU0203202063.USD","SGXZ31699556.SGD","LU0109394709.USD","LU2237443549.SGD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","LU2237443895.HKD","LU0106261372.USD","LU2456880835.USD","LU1720051108.HKD","IE0001KFT4U8.USD","SG9999015945.SGD","IE0009355771.USD","LU2237443382.USD","IE00BJJMRY28.SGD","LU0266013472.USD","LU0058720904.USD","IE00BKDWB100.SGD","IE00B775H168.HKD","LU0385154629.USD","LU0786609619.USD","LU1629891620.HKD","LU2023251221.USD","LU1623119135.USD","LU1093756325.SGD","LU1551013425.SGD","LU1064131342.USD","LU1868837300.USD","LU0096364046.USD","LU1720051017.SGD","LU1069344957.HKD","LU0006306889.USD","IE00BK4W5M84.HKD","LU2237438978.USD","LU2461242641.AUD","LU0354030511.USD","LU2468319806.SGD","LU1291159041.SGD","LU0198837287.USD","LU0964807845.USD","BK4581","LU0256863902.USD","IE00B4R5TH58.HKD","LU0323591593.USD","LU0256863811.USD","LU0708995401.HKD","LU1145028129.USD","SG9999014880.SGD","LU2271345857.HKD","LU2236285917.USD","LLYZ","LU1548497426.USD","BK4516","LU2087625088.SGD","IE00BFTCPJ56.SGD","LU2462157665.USD","LU0114720955.EUR","LU0234572021.USD","LU0943347566.SGD","LU2471134523.USD","ELIL","LU1868836591.USD","LU0203201768.USD","LU0882574139.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641149941","title":"需求扩容抵消降价压力 GLP-1赛道远期市场空间再度上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2641149941","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641149941?lang=zh_cn&edition=full","pubTime":"2026-06-05 23:18","pubTimestamp":1780672735,"startTime":"0","endTime":"0","summary":"金吾财讯 | TD Cowen上调GLP-1药物赛道远期市场预期，预计2030年全球GLP-1药物销售额将达1500亿美元，较此前1390亿美元的预测上调8%，较早年1010亿美元预期大幅抬升。需求端增量是赛道核心支撑，该机构预计2030年全球受益患者规模将从4600万增至5900万，用药需求扩容可对冲行业降价带来的营收压力。今年落地的口服GLP-1制剂商业化潜力突出，预计2030年有望占据全球总销售额的14%。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301232","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU2471134523.USD","LU2746668974.SGD","LU1551013425.SGD","LU2112291526.USD","LU0109391861.USD","LU2265009873.SGD","LU2106854487.HKD","LU2237443622.USD","LU2023250330.USD","LU2168564065.EUR","LU0689472784.USD","LU0882574055.USD","LU2237443382.USD","IE0004445015.USD","IE00BN29S564.USD","LU0354030438.USD","LU2750360641.GBP","IE0002141913.USD","LLII","SG9999015978.USD","BK4588","LU0889565916.HKD","LU0432979614.USD","LU2237443895.HKD","IE00BFSS8Q28.SGD","LU2089984988.USD","LU1868836591.USD","LU0256863811.USD","LU0203202063.USD","LLYZ","LU1323610961.USD","LU1917777945.USD","SGXZ31699556.SGD","LU0882574139.USD","LU0109394709.USD","LU0256863902.USD","SGXZ99366536.SGD","IE00BZ1G4Q59.USD","LU2168564149.EUR","LU1720051017.SGD","LU0354030511.USD","SG9999018865.SGD","LU0122379950.USD","LU0154236417.USD","BK4007","LU2213496289.HKD","LU0234572021.USD","LU0820562030.AUD","LU0058720904.USD","LU0158827781.USD","LU2089283258.USD","LU1989771016.USD","LU2361044865.SGD","SG9999014880.SGD","LU2471134879.HKD","SG9999018857.SGD","LU2456880835.USD","LU1974910355.USD","BK4581","LU1551013342.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","NVOH","LU0943347566.SGD","IE0004445239.USD","LU0158827948.USD","IE00B775H168.HKD","LU1712237335.SGD","NVO","IE00BFTCPJ56.SGD","LU0316494557.USD","LU0823434583.USD","LU0266013472.USD","LU2491050071.SGD","BK4532","IE00BK4W5L77.USD","LU2168564495.EUR","LU1069344957.HKD","IE00BKPKM429.USD","IE00BK4W5M84.HKD","LU2111349929.HKD","LU2552382132.HKD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU2756315664.SGD","LU1868837136.USD","LU2361045086.USD","LU0466842654.USD","SG9999014898.SGD","LU1064131342.USD","LU0061475181.USD","LU2063271972.USD","LU2324357040.USD","LU2462157665.USD","IE0005OL40V9.USD","LU0079474960.USD","LU0106261372.USD","LU0787776722.HKD","SG9999001176.USD","LU2089284900.SGD","LU2756315318.SGD","LU2023250504.SGD","LU0320765059.SGD","LU1280957306.USD","LU0094547139.USD","LU0456855351.SGD","LU2471134952.CNY","IE00BFSS7M15.SGD","LU0708995401.HKD","LU1804176565.USD","LU2361044949.HKD","IE0009355771.USD","LU0820561818.USD","LU0471298777.SGD","SGXZ81514606.USD","LU2237443549.SGD","LU0133085943.USD","IE00BJJMRX11.SGD","LU0210536198.USD","SG9999015952.SGD","IE00B4R5TH58.HKD","SG9999015986.USD","LU2028103732.USD","LU2602419157.SGD","IE00B7KXQ091.USD","LU1291159041.SGD","LU2552382058.USD","LU0203201768.USD","LU2491049909.HKD","LU2023251221.USD","LU0640476718.USD","LU1983299246.USD","SG9999013999.USD","SG9999017495.SGD","LU2491050154.USD","ELIL","LU2264538146.SGD","BK4534","BK4533","LU0672654240.SGD","LU0353189763.USD","LU1814569148.SGD","LU0786609619.USD","LU0006306889.USD","LU0683600562.USD","LU0417517546.SGD","LU1366192091.USD","LLYX","LU2746668461.USD","LU0225283273.USD","LU1232071149.USD","LU1623119135.USD","LU1093756325.SGD","LU1057294990.SGD","LU0353189680.USD","LU2896262040.SGD","LU2087625088.SGD","LU0471298694.HKD","LU1868836757.USD","BK4599","LU0823416689.USD","LU2211815571.USD","IE0001KFT4U8.USD","LU2237438978.USD","LU1023059063.AUD","LU2468319806.SGD","LU1093756168.USD","ELIS","LLY","LU1988902786.USD","LU2417539215.USD","LU0823434740.USD","IE00BKDWB100.SGD","IE00B1BXHZ80.USD","LU1720051108.HKD","LU2236285917.USD","LU2461242641.AUD","LU1267930730.SGD","SGXZ51526630.SGD","LU2750360997.AUD","LU0238689110.USD","BK4516","LU0289739699.SGD","SG9999014906.USD","LU2237443978.SGD","IE00B4JS1V06.HKD","SG9999014914.USD","SG9999015945.SGD","IE00B2B36J28.USD","IE00BWXC8680.SGD","LU0323591593.USD","LU2108987350.USD","NVOX","LU0964807845.USD","LU1548497426.USD","LU2237443465.HKD","IE00BKVL7J92.USD","IE00BJLML261.HKD","LU0385154629.USD","LU2168563687.JPY","LU0198837287.USD","LU1035775433.USD","LU0114720955.EUR","LU0097036916.USD","LU1061106388.HKD","LU0096364046.USD","LU1127390331.HKD","LU2271345857.HKD","LU2471134796.USD","GB00BDT5M118.USD","LU1629891620.HKD","LU0320765992.SGD","LU1868837300.USD","LU0820561909.HKD","LU2357305700.SGD","LU1868836914.USD","SG9999001176.SGD","LU2168564222.USD","BK4585","LU1145028129.USD","IE00BJJMRZ35.SGD","LU2360106947.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185465612","title":"礼来、诺和诺德涨超5%，多项并购、研发进展及产能优化利好共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1185465612","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185465612?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:57","pubTimestamp":1780585052,"startTime":"0","endTime":"0","summary":"近期利好频传。","market":"us","thumbnail":"https://static.tigerbbs.com/383539e68cf14d4cde7a90d97b6a4424","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/383539e68cf14d4cde7a90d97b6a4424"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"986bfebb17fba902db75e9cba66f1f6a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","LLY","NVO","NVOX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2640970210","title":"诺和诺德在阿联酋上市维格维口服减肥药，系美国以外首个落地市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2640970210","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640970210?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:28","pubTimestamp":1780478880,"startTime":"0","endTime":"0","summary":"诺和诺德于阿联酋推出减肥口服药维格维。这是该款药片在美国本土之外的首个上市市场。 这家丹麦药企周三宣布，减肥口服药维格维正式登陆阿联酋，这也是该药品首次在美国以外地区上市。 诺和诺德在 5 月初发布一季报时曾透露，在取得各国药监审批后，将于 2026 年下半年在部分海外国家上市这款口服减肥药，当时未披露具体落地国家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-03/doc-iniacnuq4163888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4007","IE00BKVL7J92.USD","LU1093756168.USD","LU1093756325.SGD","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","BK4599","NVO","NVOX","BK4532","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640339909","title":"Gate 股票衍生品专区将首发上线 NVO（诺和诺德）、NOK（诺基亚）等 6 个永续合约交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2640339909","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640339909?lang=zh_cn&edition=full","pubTime":"2026-06-01 13:39","pubTimestamp":1780292398,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方消息，Gate 股票衍生品专区将于 6 月 1 日 14:00（UTC+8）首发上线 NVO（诺和诺德）、NOK（诺基亚）、ASTS（AST 太空移动）、AAOI（应用光电）、INFQ (Infleqtion)、CRWD（众击）永续合约交易（USDT 结算），支持 1-20 倍杠杆。\n ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2268446","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GATE","LU1093756168.USD","IE00BMPRXN33.USD","BK4585","LU1093756325.SGD","BK4547","NOK","NVOX","BK4007","NVOH","BK4532","BK4599","LU0154236417.USD","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","IE00BMPRXR70.SGD","LNOK","NVO","BK4020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639626600","title":"诺和诺德：印度批准维格维用于青少年群体","url":"https://stock-news.laohu8.com/highlight/detail?id=2639626600","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639626600?lang=zh_cn&edition=full","pubTime":"2026-05-29 17:56","pubTimestamp":1780048560,"startTime":"0","endTime":"0","summary":"诺和诺德印度公司向彭博社书面回应称，印度中央药品标准管控局已批准爆款减肥药Wegovy 上市，适用人群为12周岁及以上、体重超60公斤（132磅） 的青少年。\n 该企业表示，儿童肥胖问题日益严峻，已成为一大公共健康难题，且会带来长期健康隐患；该药物的使用须由医护人员评估判定。\n 药企同时指出，这款药物针对青少年的用药剂量与售价将和成人版本保持一致。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：刘明亮","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-29/doc-inhzqimp7582428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4532","BK4588","IE00BZ1G4Q59.USD","BK4599","LU0154236417.USD","BK4585","IE00BKVL7J92.USD","NVO","NVOH","BK4007","LU1093756168.USD","NVOX","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637434972","title":"诺和诺德高剂量Wegovy单剂量注射笔获欧盟CHMP积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2637434972","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637434972?lang=zh_cn&edition=full","pubTime":"2026-05-23 03:00","pubTimestamp":1779476452,"startTime":"0","endTime":"0","summary":"诺和诺德于5月22日宣布，欧洲药品管理局人用药品委员会已采纳积极意见，推荐批准Wegovy 7.2 mg单剂量注射笔在欧盟上市，用于成人肥胖症患者的体重管理。此次获批的单剂量注射笔将三针合为一体，大幅提升了用药便利性。 诺和诺德预计将于2026年第三季度在欧盟正式推出Wegovy 7.2 mg单剂量注射笔。该产品已在美国以Wegovy HD品牌名上市销售。受此消息提振，诺和诺德股价当日上涨约2.4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-23/doc-inhyvhtw8043890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4007","NVOH","IE00BZ1G4Q59.USD","BK4532","BK4585","BK4599","BK4588","NVOX","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","NVO","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0307},{"period":"1month","weight":-0.0536},{"period":"3month","weight":0.3556},{"period":"6month","weight":-0.3219},{"period":"1year","weight":-0.7751},{"period":"ytd","weight":-0.3869}],"compareEarnings":[{"period":"1week","weight":0.0214},{"period":"1month","weight":0.0031},{"period":"3month","weight":0.123},{"period":"6month","weight":0.0887},{"period":"1year","weight":0.24},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"2倍做多NVO ETF-Defiance","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2倍做多NVO ETF-Defiance,NVOX,2倍做多NVO ETF-Defiance股票,2倍做多NVO ETF-Defiance股票老虎,2倍做多NVO ETF-Defiance股票老虎国际,2倍做多NVO ETF-Defiance行情,2倍做多NVO ETF-Defiance股票行情,2倍做多NVO ETF-Defiance股价,2倍做多NVO ETF-Defiance股市,2倍做多NVO ETF-Defiance股票价格,2倍做多NVO ETF-Defiance股票交易,2倍做多NVO ETF-Defiance股票购买,2倍做多NVO ETF-Defiance股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}